This study describes the development of an innovative pH-sensitive drug delivery system (DDS) utilizing ferrocene (Fc) and magnetic nanoparticles (MNPs) for cancer therapy. One potential method for generating a diverse range of functional NPs involves attaching functional substances to MNPs. In this investigation, we display the successful modification of Fe3O4 NPs by an Fc derivative (4-Ferrocenylbutyl)dimethylsilane through a hydrosilylation reaction toward the synthesis of the Fe3O4@SiO2@VTES@Fc nanocarrier (NC). The doxorubicin (DOX) drug was loaded onto Fe3O4@SiO2@VTES@Fc NC with a drug loading capacity of about 80% via π-π stacking interactions. Also, the prepared materials were thoroughly characterized using FT-IR, XRD, FE-SEM, EDX-MAP, VSM, DAPI, MTT, antioxidants, and CV techniques. In vitro studies on the release of DOX from Fe3O4@SiO2@VTES@Fc NC indicated a pH-responsive behavior with a lower release rate (< 10%) at pH 7.4 compared to pH 5 (approximately 70%) over a period of 96h. Moreover, cytotoxicity assessments demonstrated notable cytotoxic effects of DOX-loaded Fe3O4@SiO2@VTES@Fc on MCF-7 cells (IC50 value: ~8µg/mL). The study findings suggest that the fabricated magnetic core-shell NC (Fe3O4@SiO2@VTES@Fc/DOX) exhibits stimulus-responsive behavior and holds promise as a sophisticated approach to specifically transport therapeutic agents into tumor sites while minimizing exposure to healthy tissues.